Involvement of palmitate/Ca2+(Sr2+)-induced pore in the cycling of ions across the mitochondrial membrane

Biochim Biophys Acta. 2015 Feb;1848(2):488-95. doi: 10.1016/j.bbamem.2014.10.027. Epub 2014 Oct 25.

Abstract

The palmitate/Ca2+-induced (Pal/Ca2+) pore, which is formed due to the unique feature of long-chain saturated fatty acids to bind Ca2+ with high affinity, has been shown to play an important role in the physiology of mitochondria. The present study demonstrates that the efflux of Ca2+ from rat liver mitochondria induced by ruthenium red, an inhibitor of the energy-dependent Ca2+ influx, seems to be partly due to the opening of Pal/Ca2+ pores. Exogenous Pal stimulates the efflux. Measurements of pH showed that the Ca2+-induced alkalization of the mitochondrial matrix increased in the presence of Pal. The influx of Ca2+ (Sr2+) also induced an outflow of K+ followed by the reuptake of the ion by mitochondria. The outflow was not affected by a K+/H+ exchange blocker, and the reuptake was prevented by an ATP-dependent K+ channel inhibitor. It was also shown that the addition of Sr2+ to mitochondria under hypotonic conditions was accompanied by reversible cyclic changes in the membrane potential, the concentrations of Sr2+ and K+ and the respiratory rate. The cyclic changes were effectively suppressed by the inhibitors of Ca2+-dependent phospholipase A2, and a new Sr2+ cycle could only be initiated after the previous cycle was finished, indicating a refractory period in the mitochondrial sensitivity to Sr2+. All of the Ca2+- and Sr2+-induced effects were observed in the presence of cyclosporin A. This paper discusses a possible role of Pal/Ca2+ pores in the maintenance of cell ion homeostasis.

Keywords: Ca(2+) cycle; Calcium; Lipid pore; Mitochondria; Palmitic acid; Strontium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism*
  • Cations, Divalent
  • Cyclosporine / pharmacology
  • Hydrogen-Ion Concentration
  • Ion Transport
  • Membrane Potentials / drug effects
  • Mitochondria, Liver / drug effects*
  • Mitochondria, Liver / metabolism
  • Mitochondrial Membrane Transport Proteins / metabolism
  • Mitochondrial Membranes / drug effects
  • Mitochondrial Permeability Transition Pore
  • Palmitic Acid / metabolism*
  • Potassium / metabolism
  • Potassium Channel Blockers / pharmacology
  • Potassium-Hydrogen Antiporters / metabolism
  • Rats
  • Ruthenium Red / pharmacology
  • Strontium / metabolism*

Substances

  • Cations, Divalent
  • Mitochondrial Membrane Transport Proteins
  • Mitochondrial Permeability Transition Pore
  • Potassium Channel Blockers
  • Potassium-Hydrogen Antiporters
  • Ruthenium Red
  • Palmitic Acid
  • Cyclosporine
  • Potassium
  • Calcium
  • Strontium